These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15374302)

  • 1. Effect-kinetics on brain protection of two codergocrine-mesylate preparations (Aramexe retard and Hydergine) by EEG mapping and psychometry under hypoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Pakesch G; Zyhlarz G
    Arch Gerontol Geriatr; 1994; 18(2):81-99. PubMed ID: 15374302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Psychopharmacology (Berl); 1992; 109(1-2):30-40. PubMed ID: 1365669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):67-81. PubMed ID: 8721258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
    Saletu B; Grünberger J; Anderer R
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):510-24. PubMed ID: 2086492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
    Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
    Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):305-25. PubMed ID: 2127674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Br J Clin Pharmacol; 1996 Feb; 41(2):89-99. PubMed ID: 8838434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
    Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
    Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderly.
    Saletu B; Anderer P; Grünberger J
    Arch Gerontol Geriatr; 1990; 11(1):1-22. PubMed ID: 15374489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping.
    Saletu B; Anderer P; Kinsperger K; Grünberger J; Sieghart W
    Int Clin Psychopharmacol; 1988 Oct; 3(4):287-323. PubMed ID: 3235816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Semlitsch HV; Magni G
    Br J Clin Pharmacol; 1992 Jun; 33(6):589-601. PubMed ID: 1389931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
    Saletu B; Anderer P; Linzmayer L; Semlitsch HV; Lindeck-Pozza E; Assandri A; di Padova C; Saletu-Zyhlarz GM
    J Neural Transm (Vienna); 2002 Dec; 109(12):1505-26. PubMed ID: 12486491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.